Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer
1996

Oral Contraceptives, Hormone Replacement Therapy, and Colorectal Cancer Risk

Sample size: 1701 publication Evidence: moderate

Author Information

Author(s): E Fernandez, C La Vecchia, B D'Avanzo, S Franceschi, E Negri, F Parazzini

Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'

Hypothesis

Does the use of oral contraceptives and hormone replacement therapy affect the risk of colorectal cancer in women?

Conclusion

The study suggests that the use of oral contraceptives and hormone replacement therapy may decrease the risk of colorectal cancer.

Supporting Evidence

  • Women who used oral contraceptives had a multivariate odds ratio of 0.58 for colorectal cancer.
  • Women who used hormone replacement therapy had a multivariate odds ratio of 0.40 for colorectal cancer.
  • The risk of colorectal cancer decreased with longer duration of hormone replacement therapy use.

Takeaway

Using birth control pills and hormone therapy might actually help protect women from getting colon cancer.

Methodology

A case-control study involving 709 women with colorectal cancer and 992 controls, using structured interviews to gather data on hormone use and other factors.

Potential Biases

Potential selection bias due to the nature of hospital admissions for controls.

Limitations

The study has limited power due to the low frequency of OC and HRT use in the population.

Participant Demographics

Women aged less than 75 years, median age 61 for cases and 58 for controls.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI: 0.36-0.92 for OCs; 95% CI: 0.25-0.66 for HRT

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication